Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena.

NATerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 30, 2019

Primary Completion Date

February 27, 2020

Study Completion Date

February 27, 2020

Conditions
Raynaud PhenomenonPrimary Raynaud PhenomenonRaynaud DiseaseRaynaud Syndrome
Interventions
DEVICE

gammaCore Sapphire

"gammaCore SapphireTM (non-invasive vagus nerve stimulator) is intended to provide non-invasive vagus nerve stimulation (nVNS) on the side of the neck. gammaCore provides a mild electrical stimulation to the vagus nerve, which runs through the neck and carries information to the central nervous system.~Subjects will be instructed to use the gammaCore Sapphire to stimulate 2 minutes on each side of the neck, twice a day, every day. The subject controls the intensity level of the electrical stimulation."

DEVICE

Sham Device

The Sham device delivers no electrical stimulations but subjects randomized to the Sham device will received the same instructions to use the Sham device to stimulate 2 minutes on each side of the neck, twice a day, every day for the first 4 weeks after randomization.

Trial Locations (1)

43614

Unversity of Toledo Medical Center, Toledo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

ElectroCore INC

INDUSTRY

lead

University of Toledo Health Science Campus

OTHER

NCT03869008 - Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena. | Biotech Hunter | Biotech Hunter